Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
J Drugs Dermatol ; 18(6): 581, 2019 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-31251552

RESUMO

The skin is one of the largest immunologic organs in the body and a continuous target for allergic and immunologic responses. Impairment of the skin barrier increases the likelihood of external antigens and pathogens entering and creating inflammation, which can potentially lead to skin infections, allergies, and chronic inflammatory diseases such as atopic and contact dermatitis. Functionally, the skin barrier can be divided into four different levels. From outermost to innermost, these highly interdependent levels are the microbiome, chemical, physical, and immune levels. The objective of this review is to provide an update on current knowledge about the relationship between skin barrier function and how dysfunction at each level of the skin barrier can lead to allergic sensitization, contact dermatitis, and the atopic march, and examine how to best repair and maintain this barrier through the use of moisturizers. J Drugs Dermatol. 2019;18(6):581-586.


Assuntos
Dermatite Alérgica de Contato/prevenção & controle , Dermatite Atópica/prevenção & controle , Emolientes/administração & dosagem , Dermatopatias Infecciosas/prevenção & controle , Pele/metabolismo , Dermatite Alérgica de Contato/imunologia , Dermatite Alérgica de Contato/microbiologia , Dermatite Atópica/imunologia , Dermatite Atópica/microbiologia , Disbiose/imunologia , Disbiose/microbiologia , Disbiose/prevenção & controle , Humanos , Microbiota/imunologia , Permeabilidade/efeitos dos fármacos , Pele/efeitos dos fármacos , Pele/microbiologia , Creme para a Pele/administração & dosagem , Dermatopatias Infecciosas/imunologia , Dermatopatias Infecciosas/microbiologia
2.
BMC Dermatol ; 19(1): 2, 2019 01 22.
Artigo em Inglês | MEDLINE | ID: mdl-30670022

RESUMO

BACKGROUND: A defective skin barrier and bacterial colonization are two important factors in maintenance and progression of atopic dermatitis and chronic allergic/irritant hand dermatitis. A water-based lipid delivery system containing physiologic lipids was previously shown to be a useful adjunct in the treatment of hand dermatitis. We tested the ability of this formulation to penetrate into the viable epidermis and in addition assessed its antibacterial properties. METHODS: Epidermal penetration of the product was assessed by fluorescence microscopy. Recovery of Escherichia coli and Staphylococcus aureus MRSA from skin treated with Neosalus® foam was quantified. RESULTS: Components of Neosalus® penetrated the stratum corneum and were distributed throughout the viable epidermis. Neosalus® significantly decreased recovery of both Staphylococcus aureus and Escherichia coli from the skin surface. CONCLUSIONS: The ability of components of Neosalus® to be taken up into the viable epidermis and potentially made available for incorporation into the barrier lipids, combined with antibacterial properties, indicate that this formulation may be valuable not only in chronic hand dermatitis, but also in various other forms of dermatitis. TRIAL REGISTRATION: Current Controlled Trials ISRCTN18191379 , 28/12/2018, retrospectively registered.


Assuntos
Antibacterianos/administração & dosagem , Sistemas de Liberação de Medicamentos/métodos , Epiderme/efeitos dos fármacos , Adulto , Antibacterianos/farmacocinética , Dermatite Alérgica de Contato/tratamento farmacológico , Dermatite Alérgica de Contato/microbiologia , Dermatite Atópica/tratamento farmacológico , Dermatite Atópica/microbiologia , Emolientes/administração & dosagem , Emolientes/farmacocinética , Epiderme/metabolismo , Epiderme/microbiologia , Escherichia coli/isolamento & purificação , Feminino , Voluntários Saudáveis , Humanos , Lipídeos/química , Masculino , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Permeabilidade , Estudos Retrospectivos , Creme para a Pele/administração & dosagem , Creme para a Pele/farmacocinética , Resultado do Tratamento , Água/química , Adulto Jovem
4.
Technol Health Care ; 26(S1): 291-306, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29710757

RESUMO

This study was conducted according to the method presented in the Republic of Korea Pharmacopoeia 11th Revision, aseptic test method to evaluate the suitability of sterilization for a sterile needle (4 Pin Multi-needle). In this study, four tests were conducted: sterility test, cytotoxicity test, acute toxicity test, skin sensitization test. First, in the aseptic test, the microorganism was not proliferated in the aseptic test of the medium. As a result of the performance test of the medium, it was confirmed that the microorganism developed within 3 days and the fungus was evident within 5 days. Based on this, it was confirmed that the medium was suitable, and as a result of the aseptic test, the development of microorganisms was not observed during the total culture period. Based on these results, tests were conducted which were confirmed to be suitable for aseptic testing because the development of bacteria on the provided samples was not recognized. For cytotoxicity tests ISO10993-5; 2009 (Biological Evaluation of Medical Devices, Part 5: Test for in vitro Cytotoxicity). As a result, the MEM eluate of the test substance caused very slight cytotoxicity to the fibroblasts of the mouse and was judged to be Grade 1 (Slightly cytotoxic) according to the judgment standard of ISO 10993-5. On the other hand, solvent control, negative control and positive control showed the expected results on the test. Acute Toxicity Test Results: It was judged that there was no systemic toxicity change when ICR mice were treated with 50 mL/kg B.W. of the eluate of sterile injectable needle for 72 hours. Skin sensitization test result: The Hartley guinea pig was evaluated as a substance which is evaluated as a substance which does not induce any skin reaction when skin sensitization is applied to the dissected material of the sterile injectable needle and is weak in skin sensitivity. Based on the above tests, we will study the stability and efficacy of more reliable medical devices based on the verification and performance of medical devices.


Assuntos
Mesoterapia/métodos , Agulhas/microbiologia , Esterilização/métodos , Animais , Dermatite Alérgica de Contato/microbiologia , Fibroblastos/microbiologia , Cobaias , Camundongos , Reprodutibilidade dos Testes , República da Coreia , Testes Cutâneos , Esterilização/normas , Testes de Toxicidade
6.
Clin Exp Allergy ; 47(6): 805-814, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28198584

RESUMO

BACKGROUND: Being born and raised in a farm provides a long-lasting protection for allergies. The microbial environment provided by farm animals is crucial to induce this protective effect, although underlying immune mechanisms remain elusive. OBJECTIVE: To establish a mouse model of global exposure to the farming environment and to study immunologic changes linked to protection of allergy. METHODS: Mice colonies were bred in parallel in a farm cowshed and the university animal facility (AF). Mice from both locations were subjected to a skin contact allergy model. Peripheral blood cells and cell cytokine production were assessed in both populations. In addition, the gut microbiome at various ages was characterized. RESULTS: Mice born in the farm were less prone to develop allergy than mice bred in the AF. Mice transfers between the AF and the farm showed a better protection when mice were moved to the farm early in life. As compared to AF-bred mice, farm mice displayed early immune activation with higher CD4+ T cell population, in particular CD4+ CD25+ FoxP3- (activated cells). The cytokine profile of mice from the farm was skewed towards an IL-17 and IL-22 secreting cell profile accompanied by increased IL-10 secretion. These differences were mostly seen within a specific age window between birth and 8 weeks of age. Microbiome analysis showed differences between 4 and 20 weeks old mice and between farm and AF mice with an increased number of Murine mastadenovirus B in young farm mice exclusively. CONCLUSION: The farming environment provides a strong, allergy protective IL-22 stimulus and generates activated CD4+ T cells. Exposure to the farm environment early in their life may also provide a better protection for contact skin allergy. Whether a viral trigger might decisively influence protection for allergies remains to be determined.


Assuntos
Linfócitos T CD4-Positivos/imunologia , Dermatite Alérgica de Contato/imunologia , Fazendas , Microbioma Gastrointestinal/imunologia , Ativação Linfocitária/imunologia , Alérgenos/imunologia , Animais , Dermatite Alérgica de Contato/microbiologia , Camundongos , Camundongos Endogâmicos BALB C
7.
Cell Immunol ; 277(1-2): 49-57, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22726349

RESUMO

Lactobacillus plantarum CJLP133 was isolated from Kimchi, a Korean fermented food, and its potential to improve mouse atopic dermatitis after onset was studied. Dermatitis was developed through house dust-mite extract application onto NC/Nga mice, and then CJLP133 feeding was started. CJLP133 suppressed dermatitis-like skin lesions and decreased high serum IgE levels through balancing between IL-4 and IFN-γ in serum. CJLP133 diminished skin thickening, mast cell accumulation into inflamed site, and lymph node enlargement. In lymph node cells, CJLP133 repressed secretion of T cell cytokines such as IFN-γ, IL-4, IL-5, and IL-10. However, CJLP133 decreased ratios of IFN-γ and IL-5 to IL-10 in lymph node cells, while it did not decrease ratios of IL-4 and IL-5 to IFN-γ. Conclusively, CJLP133 exhibited therapeutic potential for atopic dermatitis in mice through orderly increment of type 1 helper T cell activation and regulatory T cell activation. These results suggest that CJLP133 could treat human atopic dermatitis.


Assuntos
Dermatite Alérgica de Contato/microbiologia , Dermatite Alérgica de Contato/terapia , Lactobacillus plantarum , Pyroglyphidae/imunologia , Animais , Citocinas/metabolismo , Dermatite Alérgica de Contato/patologia , Imunoglobulina E/sangue , Interferon gama/sangue , Interleucina-4/sangue , Linfonodos/metabolismo , Linfonodos/patologia , Mastócitos/patologia , Camundongos , Linfócitos T Auxiliares-Indutores/patologia , Linfócitos T Reguladores/patologia
8.
J Eur Acad Dermatol Venereol ; 25(6): 647-51, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20854306

RESUMO

BACKGROUND: Seborrhoeic dermatitis (SD) is a chronic skin disease, requiring long-term treatment, which might promote sensitization. Malassezia furfur (Mf) plays an important role in seborrhoeic dermatitis. Objectives The aim of this study was to determine the frequency of contact sensitivity in SD patients. PATIENTS AND METHODS: A total of 100 patients and 20 healthy controls (HC) were investigated: 50 suffering from SD with no previous local corticosteroid treatment (SDN), 50 SD patients treated with local corticosteroids (SDC). Mycological examination for Mf was performed. All patients were patch tested with the baseline standard, corticosteroid series, with 12 commercial corticosteroid preparations frequently used in Croatia; and also with Mf. RESULTS: Malassezia furfur was found in 44 (88%) SDN, 37 (74%) SDC, and in 4 (20%) HC; patch test reaction to Mf was positive in one SDN and in three SDC. Positive patch tests to standard allergens were observed in 17 (34%) SDN, 33 (66%) SDC and 2 (10%) HC. Patch tests to the corticosteroid series revealed positive reactions in 4 SDC and to commercial corticosteroids in seven patients, i.e. 2 SD and 5 SDC. CONCLUSIONS: Patch tests to the baseline series and to both individual corticosteroid and commercial corticosteroid preparations should be performed in SD patients with persistent dermatitis, as contact-allergic reactions may complicate their dermatitis. Sensitization to Mf was found to be infrequent.


Assuntos
Corticosteroides/efeitos adversos , Dermatite Alérgica de Contato/etiologia , Dermatite Seborreica/complicações , Dermatomicoses/imunologia , Malassezia/imunologia , Adolescente , Corticosteroides/imunologia , Corticosteroides/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Dermatite Alérgica de Contato/imunologia , Dermatite Alérgica de Contato/microbiologia , Dermatite Seborreica/tratamento farmacológico , Dermatite Seborreica/imunologia , Dermatomicoses/microbiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Testes do Emplastro , Adulto Jovem
9.
BMC Dermatol ; 6: 6, 2006 Apr 04.
Artigo em Inglês | MEDLINE | ID: mdl-16584576

RESUMO

BACKGROUND: Pruritic skin rashes associated with exposure to freshwater cyanobacteria are infrequently reported in the medical and scientific literature, mostly as anecdotal and case reports. Diagnostic dermatological investigations in humans are also infrequently described. We sought to conduct a pilot volunteer study to explore the potential for cyanobacteria to elicit hypersensitivity reactions. METHODS: A consecutive series of adult patients presenting for diagnostic skin patch testing at a hospital outpatient clinic were invited to participate. A convenience sample of volunteers matched for age and sex was also enrolled. Patches containing aqueous suspensions of various cyanobacteria at three concentrations were applied for 48 hours; dermatological assessment was made 48 hours and 96 hours after application. RESULTS: 20 outpatients and 19 reference subjects were recruited into the study. A single outpatient produced unequivocal reactions to several cyanobacteria suspensions; this subject was also the only one of the outpatient group with a diagnosis of atopic dermatitis. No subjects in the reference group developed clinically detectable skin reactions to cyanobacteria. CONCLUSION: This preliminary clinical study demonstrates that hypersensitivity reactions to cyanobacteria appear to be infrequent in both the general and dermatological outpatient populations. As cyanobacteria are widely distributed in aquatic environments, a better appreciation of risk factors, particularly with respect to allergic predisposition, may help to refine health advice given to people engaging in recreational activities where nuisance cyanobacteria are a problem.


Assuntos
Cianobactérias/patogenicidade , Citotoxinas/administração & dosagem , Dermatite Alérgica de Contato/microbiologia , Água Doce/microbiologia , Adolescente , Adulto , Idoso , Alérgenos , Animais , Chlorella vulgaris , Cianobactérias/classificação , Dermatite Alérgica de Contato/diagnóstico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Testes do Emplastro , Projetos Piloto
10.
J Environ Biol ; 27(4): 705-7, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17405335

RESUMO

Aspergillus was found as a dominant fungi to associate with brands of bindis. Among three potencies of four homeopathic drugs, Lycopodium 1M, Sulphur 1M, and Sepia 30 showed maximum inhibition zone of Aspergillus niger in inhibition zone technique. In poison food technique, Sepia 30M, Tellurium 30M, Sulphur 1M and Lycopodium 200 showed maximum percentage inhibition against A. niger


Assuntos
Antifúngicos/farmacologia , Aspergillus niger/efeitos dos fármacos , Homeopatia , Adesivos , Animais , Aspergillus niger/imunologia , Aspergillus niger/isolamento & purificação , Cosméticos , Dermatite Alérgica de Contato/microbiologia , Lycopodium/química , Testes de Sensibilidade Microbiana , Sepia/química , Enxofre/farmacologia , Telúrio/farmacologia
11.
Acta odontol. venez ; 38(2): 15-22, 2000. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-304768

RESUMO

En este estudio se determinó la respuesta alérgica a las resinas acrílicas de las dentaduras, en pacientes con ESTOMATITIS SUBPROTESICA (ES) y cultivo negativo para levaduras. De un total de 60 pacientes evaluados con diagnóstico presuntivo de ES, 41 (68,3 por ciento) resultaron con cultivo negativo. A estos 19 pacientes se les realizó un prueba alérgica del parche presentándose positividad en dos cosas (10,5 por ciento). Por otro lado se tomaron 10 pacientes portadores de prótesis dentales acrílicas sin evidencia de ES (grupo control), encontrándose dos cultivos positivos para levaduras (20 por ciento), identificándose C. albicans en ambos casos, y resultando en los 10 pacientes (100 por ciento) la prueba alérgica del parche negativa. Los resultados indican que la respuesta alérgica debe ser considerada como factor etiológico de la ES


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Dermatite Alérgica de Contato/complicações , Dermatite Alérgica de Contato/microbiologia , Estomatite sob Prótese/etiologia , Distribuição por Idade , Candida albicans , Testes do Emplastro , Resinas Acrílicas/efeitos adversos , Distribuição por Sexo , Venezuela , Leveduras
14.
Allergy Asthma Proc ; 17(3): 137-42, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8790825

RESUMO

Chronic cutaneous bacterial hypersensitivity (CCBH) is a syndrome of recurrent indolent inflammatory lesions that are caused by a hypersensitivity reaction to skin flora. It can cause significant physical and social distress to those affected, who often endure years of nondiagnostic evaluations and ineffective treatments. We report two additional cases of this syndrome. Skin testing demonstrated IgE to bacterial antigens in both patients, and ELISA demonstrated both IgE and IgG to bacterial antigens in one patient. Both patients improved rapidly and dramatically with oral corticosteroid therapy, although they failed to achieve a lasting remission, as had been seen in previous cases. These represent the fourth and fifth reported cases of CCBH. Despite failure to achieve remission, these patients demonstrate the effectiveness of an inexpensive and safe prednisone regimen in controlling this physically and socially destructive disease.


Assuntos
Anticorpos Antibacterianos/sangue , Bactérias/imunologia , Dermatite Alérgica de Contato/microbiologia , Pele/microbiologia , Adulto , Anti-Inflamatórios/uso terapêutico , Dermatite Alérgica de Contato/tratamento farmacológico , Ensaio de Imunoadsorção Enzimática , Feminino , Glucocorticoides/uso terapêutico , Humanos , Imunoglobulina E/sangue , Imunoglobulina G/sangue , Masculino , Pessoa de Meia-Idade , Prednisona/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...